| Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma (NCT00087698) | Eli Lilly and Company | 2003-09-01 |
| Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes (NCT00490659) | Eli Lilly and Company | 2003-09-01 |
| A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer (NCT00069875) | Eli Lilly and Company | 2003-09-01 |
| Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer (NCT00063401) | Eli Lilly and Company | 2003-09-01 |
| Evaluation of Continuous Symptom Treatment of ADHD (NCT00486122) | Eli Lilly and Company | 2003-09-01 |
| Bone Effects of Teriparatide Following Alendronate (NCT00191893) | Eli Lilly and Company | 2003-09-01 |
| Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge. (NCT00190814) | Eli Lilly and Company | 2003-09-01 |
| Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine) (NCT00190827) | Eli Lilly and Company | 2003-09-01 |
| Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients (NCT00191802) | Eli Lilly and Company | 2003-09-01 |
| Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder (NCT00100776) | Eli Lilly and Company | 2003-09-01 |
| Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment (NCT00191555) | Eli Lilly and Company | 2003-08-01 |
| Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis (NCT00542984) | Eli Lilly and Company | 2003-08-01 |
| Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes (NCT00191178) | Eli Lilly and Company | 2003-08-01 |
| Study of FORTEO Use in Subjects in the Community Setting (NCT01078805) | Eli Lilly and Company | 2003-08-01 |
| Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy (NCT00063570) | Eli Lilly and Company | 2003-07-01 |
| To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections (NCT00547417) | Eli Lilly and Company | 2003-07-01 |
| Intravesical Chemotherapy Treatment of Superficial Bladder Cancer (NCT00491114) | Eli Lilly and Company | 2003-07-01 |
| Duloxetine vs. Active Comparator in the Treatment of Patients With Depression (NCT00071695) | Eli Lilly and Company | 2003-07-01 |
| Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy (NCT00489983) | Eli Lilly and Company | 2003-07-01 |
| Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer (NCT00490711) | Eli Lilly and Company | 2003-07-01 |
| Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine (NCT00485407) | Eli Lilly and Company | 2003-07-01 |
| Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer (NCT00072865) | Eli Lilly and Company | 2003-06-01 |
| A Study of the Treatment of Postmenopausal Women With Osteoporosis (NCT00543023) | Eli Lilly and Company | 2003-06-01 |
| Combination Therapy in Patients With Depression (NCT00485862) | Eli Lilly and Company | 2003-06-01 |
| A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer (NCT00192075) | Eli Lilly and Company | 2003-06-01 |
| 24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine (NCT00551538) | Eli Lilly and Company | 2003-05-01 |
| Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer (NCT00063388) | Eli Lilly and Company | 2003-05-01 |
| Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer (NCT00065533) | Eli Lilly and Company | 2003-05-01 |
| Duloxetine vs. Active Comparator for the Treatment of Depression (NCT00067912) | Eli Lilly and Company | 2003-04-01 |
| Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis (NCT00532545) | Eli Lilly and Company | 2003-04-01 |
| Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection (NCT00547573) | Eli Lilly and Company | 2003-04-01 |
| Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma (NCT00491127) | Eli Lilly and Company | 2003-04-01 |
| A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI) (NCT00059215) | Eli Lilly and Company | 2003-04-01 |
| Safety Study in Outpatient Japanese Children With ADHD (NCT00485628) | Eli Lilly and Company | 2003-04-01 |
| Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics (NCT00485498) | Eli Lilly and Company | 2003-04-01 |
| Efficacy and Safety Stress Urinary Incontinence Study (NCT00475358) | Eli Lilly and Company | 2003-04-01 |
| Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer (NCT00063141) | Eli Lilly and Company | 2003-04-01 |
| Long Term Effects of Raloxifene Treatment on Bone Quality (NCT00532428) | Eli Lilly and Company | 2003-04-01 |
| Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects (NCT00547599) | Eli Lilly and Company | 2003-04-01 |
| Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus. (NCT00063128) | Eli Lilly and Company | 2003-04-01 |
| Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo (NCT00532246) | Eli Lilly and Company | 2003-03-01 |
| Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer (NCT00061815) | Eli Lilly and Company | 2003-03-01 |
| Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas (NCT00490399) | Eli Lilly and Company | 2003-03-01 |
| Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) (NCT00191139) | Eli Lilly and Company | 2003-03-01 |
| Study of Duloxetine in Elderly Patients With Major Depressive Disorder (NCT00062673) | Eli Lilly and Company | 2003-03-01 |
| A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme (NCT00191828) | Eli Lilly and Company | 2003-03-01 |
| A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation (NCT00067730) | Eli Lilly and Company | 2003-03-01 |
| Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer (NCT00191789) | Eli Lilly and Company | 2003-02-01 |
| A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer (NCT00055419) | Eli Lilly and Company | 2003-02-01 |
| Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. (NCT00061464) | Eli Lilly and Company | 2003-02-01 |
| Weight Gain Management in Patients With Schizophrenia (NCT00486005) | Eli Lilly and Company | 2003-02-01 |
| Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying (NCT00050609) | Eli Lilly and Company | 2003-02-01 |
| Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency (NCT00191360) | Eli Lilly and Company | 2003-01-01 |
| Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer (NCT00489996) | Eli Lilly and Company | 2003-01-01 |
| Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence (NCT00190996) | Eli Lilly and Company | 2003-01-01 |
| An Open Label Study of Severe Sepsis in Adults (NCT00568893) | Eli Lilly and Company | 2003-01-01 |
| A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer (NCT00055250) | Eli Lilly and Company | 2003-01-01 |
| Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy (NCT00191841) | Eli Lilly and Company | 2002-12-01 |
| Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma (NCT00061477) | Eli Lilly and Company | 2002-12-01 |
| A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated) (NCT00049777) | Eli Lilly and Company | 2002-12-01 |
| Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression (NCT00042562) | Eli Lilly and Company | 2002-12-01 |
| Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial (NCT00061451) | Eli Lilly and Company | 2002-12-01 |
| Growth Hormone Treatment in Short Children Born Small for Gestational Age (NCT00191529) | Eli Lilly and Company | 2002-12-01 |
| PTH Comparison in Post Menopausal Women (NCT00543218) | Eli Lilly and Company | 2002-12-01 |
| Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia (NCT00485823) | Eli Lilly and Company | 2002-12-01 |
| Urge Incontinence Bladder Overactivity Study (NCT00475696) | Eli Lilly and Company | 2002-11-01 |
| Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer (NCT00191763) | Eli Lilly and Company | 2002-11-01 |
| Duloxetine Versus Placebo for Fibromyalgia (NCT00489073) | Eli Lilly and Company | 2002-11-01 |
| Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease (NCT00051909) | Eli Lilly and Company | 2002-11-01 |
| Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis (NCT00049764) | Eli Lilly and Company | 2002-11-01 |
| Lispro Mix 25 vs. Glargine in Type 2 Diabetics (NCT00551356) | Eli Lilly and Company | 2002-11-01 |
| Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis (NCT00051558) | Eli Lilly and Company | 2002-11-01 |
| The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death (NCT00568737) | Eli Lilly and Company | 2002-11-01 |
| Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder (NCT00050206) | Eli Lilly and Company | 2002-11-01 |
| Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations (NCT00547287) | Eli Lilly and Company | 2002-11-01 |
| Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia (NCT00051298) | Eli Lilly and Company | 2002-11-01 |
| Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents (NCT00191438) | Eli Lilly and Company | 2002-10-01 |
| To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking (NCT00547508) | Eli Lilly and Company | 2002-10-01 |
| Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes (NCT00191282) | Eli Lilly and Company | 2002-10-01 |
| An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy (NCT00191646) | Eli Lilly and Company | 2002-10-01 |
| Combination Chemotherapy for Metastatic Breast Cancer (NCT00191815) | Eli Lilly and Company | 2002-10-01 |
| A Study of LY317615 in Patients With Brain Tumors (NCT00190723) | Eli Lilly and Company | 2002-10-01 |
| A Study for the Treatment of Painful Diabetic Neuropathy (NCT00058968) | Eli Lilly and Company | 2002-10-01 |
| Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer (NCT00191568) | Eli Lilly and Company | 2002-10-01 |
| The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis (NCT00045760) | Eli Lilly and Company | 2002-09-01 |
| A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults (NCT01088399) | Eli Lilly and Company | 2002-09-01 |
| 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis (NCT00191425) | Eli Lilly and Company | 2002-08-01 |
| Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma (NCT00044863) | Eli Lilly and Company | 2002-08-01 |
| Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes (NCT00044395) | Eli Lilly and Company | 2002-07-01 |
| A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. (NCT00191607) | Eli Lilly and Company | 2002-07-01 |
| Treatment of Peripheral Neuropathy in Patients With Diabetes (NCT00044421) | Eli Lilly and Company | 2002-07-01 |
| A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer (NCT00191490) | Eli Lilly and Company | 2002-07-01 |
| Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression (NCT00042575) | Eli Lilly and Company | 2002-06-01 |
| A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. (NCT00042679) | Eli Lilly and Company | 2002-06-01 |
| A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas. (NCT00042666) | Eli Lilly and Company | 2002-06-01 |
| Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix (NCT00191100) | Eli Lilly and Company | 2002-05-01 |
| Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder (NCT00036309) | Eli Lilly and Company | 2002-05-01 |
| The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression (NCT00035321) | Eli Lilly and Company | 2002-04-01 |
| ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. (NCT00051493) | Eli Lilly and Company | 2002-04-01 |
| Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer (NCT00191243) | Eli Lilly and Company | 2002-03-01 |